Clinico-epidemiological profile and treatment outcome of drug-resistant tuberculosis patients admitted to drug-resistant-tuberculosis center in a tertiary care hospital in Varanasi
Mishra N K, Kansal S, Mishra J K, Srivastava G N, Rajak B, Sarkar M, Shampa A, Nazmy Abdul Latheef, Maurya A, Rai B K.
Background: Tuberculosis (TB) is one of the top ten causes of mortality and the leading cause of a single infectious agent. Unfortunately, India is home to approximately one-fourth of drug-resistant (DR)-TB cases globally. Despite all the developments in TB, the disease is becoming an important threat to public health.
Objective: The present analysis was done to describe the profile and assess and compare the outcome of DR-TB patient admitted in DR-TB ward, Sir Sunderlal Hospital (SSH), Banaras Hindu University (BHU).
Materials and Methods: Retrospective analysis of data from 2013 to 2018 of multi-DR (MDR)-TB patients admitted in DR-TB ward, SSH, Institute of Medical Sciences, BHU and treatment initiated after pre-treatment evaluation was conducted. Patients were referred from nearby nine districts of Uttar Pradesh. After pre-treatment evaluation treatment was initiated at DR-TB center, SSH as well as in their respective district.
Results: A total of 3234 (76.7%) MDR-TB patients out of 4216 MDR-diagnosed patients were initiated on standard treatment which has increased from 74% in 2013. More than 93% of the cases were older than 15 years of age with slightly male predominance. The majority (>96%) of the cases were pulmonary TB. In the present analysis conversion of MDR-TB to extensively DR-TB (XDR-TB) was 7.7%. The treatment success rate for XDR-TB had also significantly improved from 11% in 2015 to 34% in 2017.
Conclusion: Analysis shows 7.7% MDR patients converted into XDR; hence, there is a strong need to explore factors responsible for conversion. 7% of patients were
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
